Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Bruce M. Camitta MD

Bruce M. Camitta MD

Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Hematology/Oncology
Program: Oncology

Member of the Cancer Center


Research Experience

  • Bone Marrow Neoplasms
  • Leukemia
  • Lymphoid Progenitor Cells
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Precursor Cells, T-Lymphoid
  • Clinical Expertise

  • Leukemia
  • Leukemia, Myeloid, Acute
  • Leukemia, Lymphoblastic, Acute
  • Publications

  • Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group. (Tower RL, Jones TL, Camitta BM, Asselin BL, Bell BA, Chauvenet A, Devidas M, Halperin EC, Pullen J, Shuster JJ, Winick N, Kurtzberg J) J Pediatr Hematol Oncol 2014 Jul;36(5):353-61 PMID 24608079
  • Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome. (Hitzler JK, He W, Doyle J, Cairo M, Camitta BM, Chan KW, Diaz Perez MA, Fraser C, Gross TG, Horan JT, Kennedy-Nasser AA, Kitko C, Kurtzberg J, Lehmann L, O'Brien T, Pulsipher MA, Smith FO, Zhang MJ, Eapen M, Carpenter PA, CIBMTR Pediatric Cancer Working Committee) Pediatr Blood Cancer 2014 Jun;61(6):1126-8 PMID 24391118
  • Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission. (Warlick ED, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM, George B, Savani BN, Ustun C, Marks DI, Waller EK, Baron F, Freytes CO, Socie G, Akpek G, Schouten HC, Lazarus HM, Horwitz EM, Koreth J, Cahn JY, Bornhauser M, Seftel M, Cairo MS, Laughlin MJ, Sabloff M, Ringdén O, Gale RP, Kamble RT, Vij R, Gergis U, Mathews V, Saber W, Chen YB, Liesveld JL, Cutler CS, Ghobadi A, Uy GL, Eapen M, Weisdorf DJ, Litzow MR) Biol Blood Marrow Transplant 2014 Feb;20(2):202-8 PMID 24184335
  • Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. (Perez-Andreu V, Roberts KG, Harvey RC, Yang W, Cheng C, Pei D, Xu H, Gastier-Foster J, E S, Lim JY, Chen IM, Fan Y, Devidas M, Borowitz MJ, Smith C, Neale G, Burchard EG, Torgerson DG, Klussmann FA, Villagran CR, Winick NJ, Camitta BM, Raetz E, Wood B, Yue F, Carroll WL, Larsen E, Bowman WP, Loh ML, Dean M, Bhojwani D, Pui CH, Evans WE, Relling MV, Hunger SP, Willman CL, Mullighan CG, Yang JJ) Nat Genet 2013 Dec;45(12):1494-8 PMID 24141364
  • Providing personalized prognostic information for adult leukemia survivors. (Lee SJ, Storer B, Wang H, Lazarus HM, Waller EK, Isola LM, Klumpp TR, Umejiego JB, Savani BN, Loren AW, Cairo MS, Camitta BM, Cutler CS, George B, Jean Khoury H, Marks DI, Rizzieri DA, Copelan EA, Gupta V, Liesveld JL, Litzow MR, Miller AM, Schouten HC, Gale RP, Cahn JY, Weisdorf DJ) Biol Blood Marrow Transplant 2013 Nov;19(11):1600-7 PMID 24018394
  • The use of novel Therakos™ Cellex® for extracorporeal photopheresis in treatment of graft-versus-host disease in paediatric patients. (Rangarajan HG, Punzalan RC, Camitta BM, Talano JA) Br J Haematol 2013 Nov;163(3):357-64 PMID 23961954
  • Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation research. (Foran JM, Pavletic SZ, Logan BR, Agovi-Johnson MA, Pérez WS, Bolwell BJ, Bornhäuser M, Bredeson CN, Cairo MS, Camitta BM, Copelan EA, Dehn J, Gale RP, George B, Gupta V, Hale GA, Lazarus HM, Litzow MR, Maharaj D, Marks DI, Martino R, Maziarz RT, Rowe JM, Rowlings PA, Savani BN, Savoie ML, Szer J, Waller EK, Wiernik PH, Weisdorf DJ) Biol Blood Marrow Transplant 2013 Jul;19(7):1102-8 PMID 23632091
  • Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia. (Ayas M, Saber W, Davies SM, Harris RE, Hale GA, Socie G, LeRademacher J, Thakar M, Deeg HJ, Al-Seraihy A, Battiwalla M, Camitta BM, Olsson R, Bajwa RS, Bonfim CM, Pasquini R, Macmillan ML, George B, Copelan EA, Wirk B, Al Jefri A, Fasth AL, Guinan EC, Horn BN, Lewis VA, Slavin S, Stepensky P, Bierings M, Gale RP) J Clin Oncol 2013 May 1;31(13):1669-76 PMID 23547077
  • Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. (Xu H, Yang W, Perez-Andreu V, Devidas M, Fan Y, Cheng C, Pei D, Scheet P, Burchard EG, Eng C, Huntsman S, Torgerson DG, Dean M, Winick NJ, Martin PL, Camitta BM, Bowman WP, Willman CL, Carroll WL, Mullighan CG, Bhojwani D, Hunger SP, Pui CH, Evans WE, Relling MV, Loh ML, Yang JJ) J Natl Cancer Inst 2013 May 15;105(10):733-42 PMID 23512250
  • Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome. (Hitzler JK, He W, Doyle J, Cairo M, Camitta BM, Chan KW, Diaz Perez MA, Fraser C, Gross TG, Horan JT, Kennedy-Nasser AA, Kitko C, Kurtzberg J, Lehmann L, O'Brien T, Pulsipher MA, Smith FO, Zhang MJ, Eapen M, Carpenter PA, CIBMTR Pediatric Cancer Working Committee) Biol Blood Marrow Transplant 2013 Jun;19(6):893-7 PMID 23467128
  • Tribute to Bart Kamen. (Camitta B) J Pediatr Hematol Oncol 2012 Nov;34(8):585-8 PMID 23108002
  • Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research. (Keating A, DaSilva G, Pérez WS, Gupta V, Cutler CS, Ballen KK, Cairo MS, Camitta BM, Champlin RE, Gajewski JL, Lazarus HM, Lill M, Marks DI, Nabhan C, Schiller GJ, Socie G, Szer J, Tallman MS, Weisdorf DJ) Haematologica 2013 Feb;98(2):185-92 PMID 22983587
  • Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. (Dunsmore KP, Devidas M, Linda SB, Borowitz MJ, Winick N, Hunger SP, Carroll WL, Camitta BM) J Clin Oncol 2012 Aug 1;30(22):2753-9 PMID 22734022
  • Outcomes after induction failure in childhood acute lymphoblastic leukemia. (Schrappe M, Hunger SP, Pui CH, Saha V, Gaynon PS, Baruchel A, Conter V, Otten J, Ohara A, Versluys AB, Escherich G, Heyman M, Silverman LB, Horibe K, Mann G, Camitta BM, Harbott J, Riehm H, Richards S, Devidas M, Zimmermann M) N Engl J Med 2012 Apr 12;366(15):1371-81 PMID 22494120
  • Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. (Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, Reaman GH, Carroll WL) J Clin Oncol 2012 May 10;30(14):1663-9 PMID 22412151
  • Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia. (Zhang MJ, Davies SM, Camitta BM, Logan B, Tiedemann K, Eapen M, Thiel EL) Biol Blood Marrow Transplant 2012 Aug;18(8):1204-10 PMID 22406037
  • Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study. (Chen IM, Harvey RC, Mullighan CG, Gastier-Foster J, Wharton W, Kang H, Borowitz MJ, Camitta BM, Carroll AJ, Devidas M, Pullen DJ, Payne-Turner D, Tasian SK, Reshmi S, Cottrell CE, Reaman GH, Bowman WP, Carroll WL, Loh ML, Winick NJ, Hunger SP, Willman CL) Blood 2012 Apr 12;119(15):3512-22 PMID 22368272
  • Imatinib resistant BCR-ABL1 mutations at relapse in children with Ph+ ALL: a Children's Oncology Group (COG) study. (Chang BH, Willis SG, Stork L, Hunger SP, Carroll WL, Camitta BM, Winick NJ, Druker BJ, Schultz KR) Br J Haematol 2012 May;157(4):507-10 PMID 22299775
  • ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. (Xu H, Cheng C, Devidas M, Pei D, Fan Y, Yang W, Neale G, Scheet P, Burchard EG, Torgerson DG, Eng C, Dean M, Antillon F, Winick NJ, Martin PL, Willman CL, Camitta BM, Reaman GH, Carroll WL, Loh M, Evans WE, Pui CH, Hunger SP, Relling MV, Yang JJ) J Clin Oncol 2012 Mar 1;30(7):751-7 PMID 22291082
  • Role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review. (Oliansky DM, Camitta B, Gaynon P, Nieder ML, Parsons SK, Pulsipher MA, Dillon H, Ratko TA, Wall D, McCarthy PL Jr, Hahn T, American Society for Blood and Marrow Transplantation) Biol Blood Marrow Transplant 2012 Apr;18(4):505-22 PMID 22209888
  • Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866). (Kurtzberg J, Asselin B, Bernstein M, Buchanan GR, Pollock BH, Camitta BM) J Pediatr Hematol Oncol 2011 Dec;33(8):610-6 PMID 22042277
  • Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study. (Armand P, Kim HT, Zhang MJ, Perez WS, Dal Cin PS, Klumpp TR, Waller EK, Litzow MR, Liesveld JL, Lazarus HM, Artz AS, Gupta V, Savani BN, McCarthy PL, Cahn JY, Schouten HC, Finke J, Ball ED, Aljurf MD, Cutler CS, Rowe JM, Antin JH, Isola LM, Di Bartolomeo P, Camitta BM, Miller AM, Cairo MS, Stockerl-Goldstein K, Sierra J, Savoie ML, Halter J, Stiff PJ, Nabhan C, Jakubowski AA, Bunjes DW, Petersdorf EW, Devine SM, Maziarz RT, Bornhauser M, Lewis VA, Marks DI, Bredeson CN, Soiffer RJ, Weisdorf DJ) Biol Blood Marrow Transplant 2012 Feb;18(2):280-8 PMID 21810400
  • Treatment of recurrent CNS disease post-bone marrow transplant in familial HLH. (Rangarajan HG, Grochowski D, Mulberry MF, Gheorghe G, Camitta BM, Talano JA) Pediatr Blood Cancer 2012 Jul 15;59(1):189-90 PMID 21755594
  • Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. (Zhang J, Mullighan CG, Harvey RC, Wu G, Chen X, Edmonson M, Buetow KH, Carroll WL, Chen IM, Devidas M, Gerhard DS, Loh ML, Reaman GH, Relling MV, Camitta BM, Bowman WP, Smith MA, Willman CL, Downing JR, Hunger SP) Blood 2011 Sep 15;118(11):3080-7 PMID 21680795
  • Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404). (Asselin BL, Devidas M, Wang C, Pullen J, Borowitz MJ, Hutchison R, Lipshultz SE, Camitta BM) Blood 2011 Jul 28;118(4):874-83 PMID 21474675
  • Mycobacterium avium intracellulare infection coexistent with nodular lymphocyte predominant Hodgkin lymphoma involving the lung. (Gupta S, Cogbill CH, Gheorghe G, Rao AR, Kumar S, Havens PL, Camitta BM, Warwick AB) J Pediatr Hematol Oncol 2011 Apr;33(3):e127-31 PMID 21399527
  • Plasma methotrexate, red blood cell methotrexate, and red blood cell folate values and outcome in children with precursor B-acute lymphoblastic leukemia: a report from the Children's Oncology Group. (Salzer WL, Winick NJ, Wacker P, Lu X, Devidas M, Shuster JJ, Mahoney DH, Lauer SJ, Camitta BM) J Pediatr Hematol Oncol 2012 Jan;34(1):e1-7 PMID 21364468
  • Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906. (Bowman WP, Larsen EL, Devidas M, Linda SB, Blach L, Carroll AJ, Carroll WL, Pullen DJ, Shuster J, Willman CL, Winick N, Camitta BM, Hunger SP, Borowitz MJ) Pediatr Blood Cancer 2011 Oct;57(4):569-77 PMID 21360654
  • Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. (Yang JJ, Cheng C, Devidas M, Cao X, Fan Y, Campana D, Yang W, Neale G, Cox NJ, Scheet P, Borowitz MJ, Winick NJ, Martin PL, Willman CL, Bowman WP, Camitta BM, Carroll A, Reaman GH, Carroll WL, Loh M, Hunger SP, Pui CH, Evans WE, Relling MV) Nat Genet 2011 Mar;43(3):237-41 PMID 21297632
  • Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group. (Dreyer ZE, Dinndorf PA, Camitta B, Sather H, La MK, Devidas M, Hilden JM, Heerema NA, Sanders JE, McGlennen R, Willman CL, Carroll AJ, Behm F, Smith FO, Woods WG, Godder K, Reaman GH) J Clin Oncol 2011 Jan 10;29(2):214-22 PMID 21135279
  • Philadelphia chromosome-positive acute lymphoblastic leukemia in children: new and emerging treatment options. (Schultz KR, Prestidge T, Camitta B) Expert Rev Hematol 2010 Dec;3(6):731-42 PMID 21091149
  • Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia. (Chu R, Brazauskas R, Kan F, Bashey A, Bredeson C, Camitta B, Chiang KY, Frangoul H, Gale RP, Gee A, George B, Goldman FD, Gross TG, Gupta V, Hale GA, Isola L, Ispizua AU, Lazarus H, Marsh J, Russell J, Sabloff M, Waller EK, Eapen M) Biol Blood Marrow Transplant 2011 Jul;17(7):1018-24 PMID 21034842
  • Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. (Harvey RC, Mullighan CG, Wang X, Dobbin KK, Davidson GS, Bedrick EJ, Chen IM, Atlas SR, Kang H, Ar K, Wilson CS, Wharton W, Murphy M, Devidas M, Carroll AJ, Borowitz MJ, Bowman WP, Downing JR, Relling M, Yang J, Bhojwani D, Carroll WL, Camitta B, Reaman GH, Smith M, Hunger SP, Willman CL) Blood 2010 Dec 2;116(23):4874-84 PMID 20699438
  • Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. (Duval M, Klein JP, He W, Cahn JY, Cairo M, Camitta BM, Kamble R, Copelan E, de Lima M, Gupta V, Keating A, Lazarus HM, Litzow MR, Marks DI, Maziarz RT, Rizzieri DA, Schiller G, Schultz KR, Tallman MS, Weisdorf D) J Clin Oncol 2010 Aug 10;28(23):3730-8 PMID 20625136
  • Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party. (Marsh J, Socie G, Tichelli A, Schrezenmeier H, Hochsmann B, Risitano AM, Fuehrer M, Bekassy AN, Korthof ET, Locasciulli A, Ljungman P, Bacigalupo A, Camitta B, Young NS, Passweg J, European Group for Blood and Marrow Transplantation (EBMT) Severe Aplastic Anaemia Working Party) Br J Haematol 2010 Aug;150(3):377-9 PMID 20528874
  • Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group. (Maloney KW, Carroll WL, Carroll AJ, Devidas M, Borowitz MJ, Martin PL, Pullen J, Whitlock JA, Willman CL, Winick NJ, Camitta BM, Hunger SP) Blood 2010 Aug 19;116(7):1045-50 PMID 20442364
  • Absidia corymbifera endocarditis: survival after treatment of disseminated mucormycosis with radical resection of tricuspid valve and right ventricular free wall. (Mitchell ME, McManus M, Dietz J, Camitta BM, Szabo S, Havens P) J Thorac Cardiovasc Surg 2010 Apr;139(4):e71-2 PMID 20304127
  • Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. (Harvey RC, Mullighan CG, Chen IM, Wharton W, Mikhail FM, Carroll AJ, Kang H, Liu W, Dobbin KK, Smith MA, Carroll WL, Devidas M, Bowman WP, Camitta BM, Reaman GH, Hunger SP, Downing JR, Willman CL) Blood 2010 Jul 1;115(26):5312-21 PMID 20139093
  • Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. (Litzow MR, Tarima S, Pérez WS, Bolwell BJ, Cairo MS, Camitta BM, Cutler CS, de Lima M, Dipersio JF, Gale RP, Keating A, Lazarus HM, Luger S, Marks DI, Maziarz RT, McCarthy PL, Pasquini MC, Phillips GL, Rizzo JD, Sierra J, Tallman MS, Weisdorf DJ) Blood 2010 Mar 4;115(9):1850-7 PMID 20032503
  • Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group. (Salzer WL, Devidas M, Carroll WL, Winick N, Pullen J, Hunger SP, Camitta BA) Leukemia 2010 Feb;24(2):355-70 PMID 20016527
  • High-dose chemotherapy with blood or bone marrow transplants for rhabdomyosarcoma. (Stiff PJ, Agovi MA, Antman KH, Blaise D, Camitta BM, Cairo MS, Childs RW, Edwards JR, Gale RP, Hale GA, Lazarus HM, Arora M) Biol Blood Marrow Transplant 2010 Apr;16(4):525-32 PMID 19961947
  • Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. (Kang H, Chen IM, Wilson CS, Bedrick EJ, Harvey RC, Atlas SR, Devidas M, Mullighan CG, Wang X, Murphy M, Ar K, Wharton W, Borowitz MJ, Bowman WP, Bhojwani D, Carroll WL, Camitta BM, Reaman GH, Smith MA, Downing JR, Hunger SP, Willman CL) Blood 2010 Feb 18;115(7):1394-405 PMID 19880498
  • Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study. (Schultz KR, Bowman WP, Aledo A, Slayton WB, Sather H, Devidas M, Wang C, Davies SM, Gaynon PS, Trigg M, Rutledge R, Burden L, Jorstad D, Carroll A, Heerema NA, Winick N, Borowitz MJ, Hunger SP, Carroll WL, Camitta B) J Clin Oncol 2009 Nov 1;27(31):5175-81 PMID 19805687
  • Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents. (Gross TG, Hale GA, He W, Camitta BM, Sanders JE, Cairo MS, Hayashi RJ, Termuhlen AM, Zhang MJ, Davies SM, Eapen M) Biol Blood Marrow Transplant 2010 Feb;16(2):223-30 PMID 19800015
  • Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia. (Horan JT, Carreras J, Tarima S, Camitta BM, Gale RP, Hale GA, Hinterberger W, Marsh J, Passweg JR, Walters MC, Eapen M) Biol Blood Marrow Transplant 2009 May;15(5):626-31 PMID 19361755
  • Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. (Yang JJ, Cheng C, Yang W, Pei D, Cao X, Fan Y, Pounds SB, Neale G, Treviño LR, French D, Campana D, Downing JR, Evans WE, Pui CH, Devidas M, Bowman WP, Camitta BM, Willman CL, Davies SM, Borowitz MJ, Carroll WL, Hunger SP, Relling MV) JAMA 2009 Jan 28;301(4):393-403 PMID 19176441
  • HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. (Pasquini R, Carreras J, Pasquini MC, Camitta BM, Fasth AL, Hale GA, Harris RE, Marsh JC, Robinson AJ, Zhang MJ, Eapen M, Wagner JE) Biol Blood Marrow Transplant 2008 Oct;14(10):1141-7 PMID 18804044
  • Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapy. (Bunin NJ, Davies SM, Aplenc R, Camitta BM, DeSantes KB, Goyal RK, Kapoor N, Kernan NA, Rosenthal J, Smith FO, Eapen M) J Clin Oncol 2008 Sep 10;26(26):4326-32 PMID 18779619
  • Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected]. (Raetz EA, Borowitz MJ, Devidas M, Linda SB, Hunger SP, Winick NJ, Camitta BM, Gaynon PS, Carroll WL) J Clin Oncol 2008 Aug 20;26(24):3971-8 PMID 18711187
  • Sequential oral hydroxyurea and intravenous cytosine arabinoside in refractory childhood acute leukemia: a pediatric oncology group phase 1 study. (Dubowy R, Graham M, Hakami N, Kletzel M, Mahoney D, Newman E, Ravindranath Y, Camitta B) J Pediatr Hematol Oncol 2008 May;30(5):353-7 PMID 18458568
  • Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. (Rubnitz JE, Wichlan D, Devidas M, Shuster J, Linda SB, Kurtzberg J, Bell B, Hunger SP, Chauvenet A, Pui CH, Camitta B, Pullen J, Children's Oncology Group) J Clin Oncol 2008 May 1;26(13):2186-91 PMID 18445843
  • Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. (Borowitz MJ, Devidas M, Hunger SP, Bowman WP, Carroll AJ, Carroll WL, Linda S, Martin PL, Pullen DJ, Viswanatha D, Willman CL, Winick N, Camitta BM, Children's Oncology Group) Blood 2008 Jun 15;111(12):5477-85 PMID 18388178
  • Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma. (Gardner SL, Carreras J, Boudreau C, Camitta BM, Adams RH, Chen AR, Davies SM, Edwards JR, Grovas AC, Hale GA, Lazarus HM, Arora M, Stiff PJ, Eapen M) Bone Marrow Transplant 2008 May;41(10):867-72 PMID 18246113
  • Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. (Eapen M, Zhang MJ, Devidas M, Raetz E, Barredo JC, Ritchey AK, Godder K, Grupp S, Lewis VA, Malloy K, Carroll WL, Davies SM, Camitta BM, Children's Oncology Group, Center for International Blood and Marrow Transplant Research) Leukemia 2008 Feb;22(2):281-6 PMID 18033318
  • Allergic reactions to E. coli L-asparaginase do not affect outcome in childhood B-precursor acute lymphoblastic leukemia: a Children's Oncology Group Study. (Wacker P, Land VJ, Camitta BM, Kurtzberg J, Pullen J, Harris MB, Shuster JJ, Children's Oncology Study Group) J Pediatr Hematol Oncol 2007 Sep;29(9):627-32 PMID 17805038
  • Prognostic significance of cytogenetically detected chromosome 21 anomalies in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. (Cooley LD, Chenevert S, Shuster JJ, Johnston DA, Mahoney DH, Carroll AJ, Devidas M, Linda SB, Lauer SJ, Camitta BM) Cancer Genet Cytogenet 2007 Jun;175(2):117-24 PMID 17556067
  • Intensified PEG-L-asparaginase and antimetabolite-based therapy for treatment of higher risk precursor-B acute lymphoblastic leukemia: a report from the Children's Oncology Group. (Salzer WL, Devidas M, Shuster JJ, Wang C, Chauvenet A, Asselin BL, Camitta BM, Kurtzberg J, Children's Oncology Group) J Pediatr Hematol Oncol 2007 Jun;29(6):369-75 PMID 17551397
  • Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. (Schrezenmeier H, Passweg JR, Marsh JC, Bacigalupo A, Bredeson CN, Bullorsky E, Camitta BM, Champlin RE, Gale RP, Fuhrer M, Klein JP, Locasciulli A, Oneto R, Schattenberg AV, Socie G, Eapen M) Blood 2007 Aug 15;110(4):1397-400 PMID 17475907
  • Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia. (Nachman JB, Heerema NA, Sather H, Camitta B, Forestier E, Harrison CJ, Dastugue N, Schrappe M, Pui CH, Basso G, Silverman LB, Janka-Schaub GE) Blood 2007 Aug 15;110(4):1112-5 PMID 17473063
  • Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201. (Chauvenet AR, Martin PL, Devidas M, Linda SB, Bell BA, Kurtzberg J, Pullen J, Pettenati MJ, Carroll AJ, Shuster JJ, Camitta B) Blood 2007 Aug 15;110(4):1105-11 PMID 17442849
  • Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia. (Heerema NA, Raimondi SC, Anderson JR, Biegel J, Camitta BM, Cooley LD, Gaynon PS, Hirsch B, Magenis RE, McGavran L, Patil S, Pettenati MJ, Pullen J, Rao K, Roulston D, Schneider NR, Shuster JJ, Sanger W, Sutcliffe MJ, van Tuinen P, Watson MS, Carroll AJ) Genes Chromosomes Cancer 2007 Jul;46(7):684-93 PMID 17431878
  • Gene expression overlap affects karyotype prediction in pediatric acute lymphoblastic leukemia. (Martin SB, Mosquera-Caro MP, Potter JW, Davidson GS, Andries E, Kang H, Helman P, Veroff RL, Atlas SR, Murphy M, Wang X, Ar K, Xu Y, Chen IM, Schultz FA, Wilson CS, Harvey R, Bedrick E, Shuster J, Carroll AJ, Camitta B, Willman CL) Leukemia 2007 Jun;21(6):1341-4 PMID 17410195
  • Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens. (Champlin RE, Perez WS, Passweg JR, Klein JP, Camitta BM, Gluckman E, Bredeson CN, Eapen M, Horowitz MM) Blood 2007 May 15;109(10):4582-5 PMID 17272503
  • Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia. (Thompson PA, Murry DJ, Rosner GL, Lunagomez S, Blaney SM, Berg SL, Camitta BM, Dreyer ZE, Bomgaars LR) Cancer Chemother Pharmacol 2007 May;59(6):847-53 PMID 17136402
  • Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). (Schultz KR, Pullen DJ, Sather HN, Shuster JJ, Devidas M, Borowitz MJ, Carroll AJ, Heerema NA, Rubnitz JE, Loh ML, Raetz EA, Winick NJ, Hunger SP, Carroll WL, Gaynon PS, Camitta BM) Blood 2007 Feb 1;109(3):926-35 PMID 17003380
  • Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study. (Barredo JC, Devidas M, Lauer SJ, Billett A, Marymont M, Pullen J, Camitta B, Winick N, Carroll W, Ritchey AK) J Clin Oncol 2006 Jul 1;24(19):3142-9 PMID 16809737
  • Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. (Eapen M, Raetz E, Zhang MJ, Muehlenbein C, Devidas M, Abshire T, Billett A, Homans A, Camitta B, Carroll WL, Davies SM, Children's Oncology Group, Center for International Blood and Marrow Transplant Research) Blood 2006 Jun 15;107(12):4961-7 PMID 16493003
  • Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. (Passweg JR, Pérez WS, Eapen M, Camitta BM, Gluckman E, Hinterberger W, Hows JM, Marsh JC, Pasquini R, Schrezenmeier H, Socié G, Zhang MJ, Bredeson C) Bone Marrow Transplant 2006 Apr;37(7):641-9 PMID 16489361
  • The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review. (Hahn T, Wall D, Camitta B, Davies S, Dillon H, Gaynon P, Larson RA, Parsons S, Seidenfeld J, Weisdorf D, McCarthy PL Jr) Biol Blood Marrow Transplant 2006 Jan;12(1):1-30 PMID 16399566
  • Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. (Eapen M, Rubinstein P, Zhang MJ, Camitta BM, Stevens C, Cairo MS, Davies SM, Doyle JJ, Kurtzberg J, Pulsipher MA, Ortega JJ, Scaradavou A, Horowitz MM, Wagner JE) J Clin Oncol 2006 Jan 1;24(1):145-51 PMID 16382124
  • Pyrite or true gold? (Burns K, Camitta B) J Pediatr Hematol Oncol 2005 Dec;27(12):696-8 PMID 16344682
  • The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review. (Hahn T, Wall D, Camitta B, Davies S, Dillon H, Gaynon P, Larson RA, Parsons S, Seidenfeld J, Weisdorf D, McCarthy PL Jr) Biol Blood Marrow Transplant 2005 Nov;11(11):823-61 PMID 16275588
  • Does intravenous 6-mercaptopurine decrease salvage after relapse in childhood acute lymphoblastic leukemia? (Mahoney DH Jr, Camitta BM, Devidas M) Pediatr Blood Cancer 2006 May 1;46(5):660-1 PMID 16276523
  • Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL. (Talano JM, Casper JT, Camitta BM, Keever-Taylor CA, Murray KJ, Eapen M, Pierce KL, Margolis DA) Bone Marrow Transplant 2006 Jan;37(2):135-41 PMID 16273115
  • Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group. (Borowitz MJ, Pullen DJ, Winick N, Martin PL, Bowman WP, Camitta B) Cytometry B Clin Cytom 2005 Nov;68(1):18-24 PMID 16184615
  • Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States. (Baker KS, Loberiza FR Jr, Yu H, Cairo MS, Bolwell BJ, Bujan-Boza WA, Camitta BM, Garcia JJ, Ho WG, Liesveld JL, Maharaj D, Marks DI, Schultz KR, Wiernik P, Zander AR, Horowitz MM, Keating A, Weisdorf DJ) J Clin Oncol 2005 Oct 1;23(28):7032-42 PMID 16145067
  • Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. (Ravindranath Y, Chang M, Steuber CP, Becton D, Dahl G, Civin C, Camitta B, Carroll A, Raimondi SC, Weinstein HJ, Pediatric Oncology Group) Leukemia 2005 Dec;19(12):2101-16 PMID 16136167
  • Pyrite or true gold? (Burns K, Camitta B) J Pediatr Hematol Oncol 2005 May;27(5):244-5 PMID 15891556
  • High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative. (Sutcliffe MJ, Shuster JJ, Sather HN, Camitta BM, Pullen J, Schultz KR, Borowitz MJ, Gaynon PS, Carroll AJ, Heerema NA) Leukemia 2005 May;19(5):734-40 PMID 15789069
  • Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment outcome in children with B-progenitor-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. (Whitehead VM, Shuster JJ, Vuchich MJ, Mahoney DH Jr, Lauer SJ, Payment C, Koch PA, Cooley LD, Look AT, Pullen DJ, Camitta B) Leukemia 2005 Apr;19(4):533-6 PMID 15716987
  • Pyrite or true gold? Case 1. (Camitta BM) J Pediatr Hematol Oncol 2005 Feb;27(2):61 PMID 15701977
  • Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial. (Jeha S, Kantarjian H, Irwin D, Shen V, Shenoy S, Blaney S, Camitta B, Pui CH) Leukemia 2005 Jan;19(1):34-8 PMID 15510203
  • Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis. (Godder K, Eapen M, Laver JH, Zhang MJ, Camitta BM, Wayne AS, Gale RP, Doyle JJ, Yu LC, Chen AR, Garvin JH Jr, Sandler ES, Yeager AM, Edwards JR, Horowitz MM) J Clin Oncol 2004 Sep 15;22(18):3798-804 PMID 15365077
  • Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. (Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, Tallman MS, Marks DI, Camitta BM, Champlin RE, Ringdén O, Bredeson CN, Martino R, Gale RP, Cairo MS, Litzow MR, deLima M) Bone Marrow Transplant 2004 Oct;34(8):721-7 PMID 15322568
  • A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: a Pediatric Oncology Group study (now The Children's Oncology Group). (Bell BA, Brockway GN, Shuster JJ, Erdmann G, Sterikoff S, Bostrom B, Camitta BM, Pediatric Oncology Group study (now The Children's Oncology Group)) Pediatr Blood Cancer 2004 Aug;43(2):105-9 PMID 15236274
  • PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5. (Schuetz EG, Relling MV, Kishi S, Yang W, Das S, Chen P, Cook EH, Rosner GL, Pui CH, Blanco JG, Edick MJ, Hancock ML, Winick NJ, Dervieux T, Amylon MD, Bash RO, Behm FG, Camitta BM, Raimondi SC, Goh BC, Lee SC, Wang LZ, Fan L, Guo JY, Lamba J, Lim R, Lim HL, Ong AB, Lee HS, Kuehl P, Zhang J, Lin Y, Assem M, Schuetz J, Watkins PB, Daly A, Wrighton SA, Hall SD, Maurel P, Brimer C, Yasuda K, Venkataramanan R, Strom S, Thummel K, Boguski MS) Pharmacol Rev 2004 Jun;56(2):159 PMID 15169924
  • Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome. (Heerema NA, Harbott J, Galimberti S, Camitta BM, Gaynon PS, Janka-Schaub G, Kamps W, Basso G, Pui CH, Schrappe M, Auclerc MF, Carroll AJ, Conter V, Harrison CJ, Pullen J, Raimondi SC, Richards S, Riehm H, Sather HN, Shuster JJ, Silverman LB, Valsecchi MG, Aricò M, Acute Lymphoblastic Leukemia Study Groups, ALL-BFM, CoALL, AIEOP, DCLSG, FRALLE, CCG, DFCI, POG, St Jude, UKALL) Leukemia 2004 Apr;18(4):693-702 PMID 15044926
  • In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. (Ramakers-van Woerden NL, Beverloo HB, Veerman AJ, Camitta BM, Loonen AH, van Wering ER, Slater RM, Harbott J, den Boer ML, Ludwig WD, Haas OA, Janka-Schaub GE, Pieters R) Leukemia 2004 Mar;18(3):521-9 PMID 14712291
  • Evaluation of histogenesis of B-lymphocytes in pediatric EBV-related post-transplant lymphoproliferative disorders. (Abed N, Casper JT, Camitta BM, Margolis D, Trost B, Orentas R, Chang CC) Bone Marrow Transplant 2004 Feb;33(3):321-7 PMID 14688820
  • The surgeon's role in pediatric orbital malignancies: an oncologist's perspective. (Browning MB, Camitta BM) Ophthal Plast Reconstr Surg 2003 Sep;19(5):340-4 PMID 14506417
  • Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study. (Borowitz MJ, Pullen DJ, Shuster JJ, Viswanatha D, Montgomery K, Willman CL, Camitta B, Children's Oncology Group study) Leukemia 2003 Aug;17(8):1566-72 PMID 12886244
  • Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. (Pui CH, Chessells JM, Camitta B, Baruchel A, Biondi A, Boyett JM, Carroll A, Eden OB, Evans WE, Gadner H, Harbott J, Harms DO, Harrison CJ, Harrison PL, Heerema N, Janka-Schaub G, Kamps W, Masera G, Pullen J, Raimondi SC, Richards S, Riehm H, Sallan S, Sather H, Shuster J, Silverman LB, Valsecchi MG, Vilmer E, Zhou Y, Gaynon PS, Schrappe M) Leukemia 2003 Apr;17(4):700-6 PMID 12682627
  • Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission. (Litzow MR, Pérez WS, Klein JP, Bolwell BJ, Camitta B, Copelan EA, Gale RP, Giralt SA, Keating A, Lazarus HM, Marks DI, McCarthy PL, Miller CB, Milone G, Prentice HG, Russell JA, Schultz KR, Trigg ME, Weisdorf DJ, Horowitz MM) Br J Haematol 2002 Dec;119(4):1115-24 PMID 12472596
  • Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies. (Blanco JG, Edick MJ, Hancock ML, Winick NJ, Dervieux T, Amylon MD, Bash RO, Behm FG, Camitta BM, Pui CH, Raimondi SC, Relling MV) Pharmacogenetics 2002 Nov;12(8):605-11 PMID 12439220
  • Cognitive and psychosocial functioning of pediatric hematopoietic stem cell transplant patients: a prospective longitudinal study. (Kupst MJ, Penati B, Debban B, Camitta B, Pietryga D, Margolis D, Murray K, Casper J) Bone Marrow Transplant 2002 Nov;30(9):609-17 PMID 12407436
  • An infant with subvalvar and valvar aortic stenosis, subvalvar and valvar pulmonary stenosis, severe biventricular hypertrophy and pulmonary hemorrhage. (Milazzo AS, Golioto A, Camitta MG, O'Laughlin MP) Pediatr Cardiol 2003 Mar-Apr;24(2):169-71 PMID 12360389
  • Minimax two-stage-designs with applications to tissue banking case-control studies. (Shuster J, Link M, Camitta B, Pullen J, Behm F) Stat Med 2002 Sep 15;21(17):2479-93 PMID 12205694
  • Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. (Pui CH, Gaynon PS, Boyett JM, Chessells JM, Baruchel A, Kamps W, Silverman LB, Biondi A, Harms DO, Vilmer E, Schrappe M, Camitta B) Lancet 2002 Jun 1;359(9321):1909-15 PMID 12057554
  • Bone marrow stroma-supported culture of T-lineage acute lymphoblastic leukemic cells predicts treatment outcome in children: a Pediatric Oncology Group study. (Winter SS, Sweatman J, Shuster JJ, Link MP, Amylon MD, Pullen J, Camitta BM, Larson RS) Leukemia 2002 Jun;16(6):1121-6 PMID 12040442
  • Intermediate-dose methotrexate and intravenous 6-mercaptopurine chemotherapy for children with acute lymphoblastic leukemia who did not respond to initial induction therapy. (Ogden AK, Pollock BH, Bernstein ML, Camitta B, Buchanan GR) J Pediatr Hematol Oncol 2002 Mar-Apr;24(3):182-7 PMID 11990303
  • Infants with acute lymphoblastic leukemia: no evidence for high methotrexate resistance. (Ramakers-van Woerden NL, Pieters R, Rots MG, van Zantwijk CH, Noordhuis P, Beverloo HB, Peters GJ, van Wering ER, Camitta BM, Pui CH, Relling MV, Evans WE, Veerman AJ) Leukemia 2002 May;16(5):949-51 PMID 11986959
  • Inhibition of Bcl-xL expression sensitizes T-cell acute lymphoblastic leukemia cells to chemotherapeutic drugs. (Broome HE, Yu AL, Diccianni M, Camitta BM, Monia BP, Dean NM) Leuk Res 2002 Mar;26(3):311-6 PMID 11792421
  • Cyclooxygenase-1 and -2 knockout mice demonstrate increased cardiac ischemia/reperfusion injury but are protected by acute preconditioning. (Camitta MG, Gabel SA, Chulada P, Bradbury JA, Langenbach R, Zeldin DC, Murphy E) Circulation 2001 Nov 13;104(20):2453-8 PMID 11705824
  • Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial. (Pui CH, Jeha S, Irwin D, Camitta B) Leukemia 2001 Oct;15(10):1505-9 PMID 11587206
  • Thioredoxin expression in primary T-cell acute lymphoblastic leukemia and its therapeutic implication. (Shao L, Diccianni MB, Tanaka T, Gribi R, Yu AL, Pullen JD, Camitta BM, Yu J) Cancer Res 2001 Oct 1;61(19):7333-8 PMID 11585774
  • A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trial. (Lauer SJ, Shuster JJ, Mahoney DH Jr, Winick N, Toledano S, Munoz L, Kiefer G, Pullen JD, Steuber CP, Camitta BM) Leukemia 2001 Jul;15(7):1038-45 PMID 11455971
  • The association of the TEL-AML1 chromosomal translocation with the accumulation of methotrexate polyglutamates in lymphoblasts and with ploidy in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. (Whitehead VM, Payment C, Cooley L, Lauer SJ, Mahoney DH, Shuster JJ, Vuchich MJ, Bernstein ML, Look AT, Pullen DJ, Camitta B) Leukemia 2001 Jul;15(7):1081-8 PMID 11455977
  • Vesiculopustular eruptions in Down syndrome neonates with myeloproliferative disorders. (Nijhawan A, Baselga E, Gonzalez-Ensenat MA, Vicente A, Southern JF, Camitta BM, Esterly NB, Drolet BA) Arch Dermatol 2001 Jun;137(6):760-3 PMID 11405767
  • Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. (Schrappe M, Camitta B, Pui CH, Eden T, Gaynon P, Gustafsson G, Janka-Schaub GE, Kamps W, Masera G, Sallan S, Tsuchida M, Vilmer E) Leukemia 2000 Dec;14(12):2193-4 PMID 11187910
  • Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994. (Maloney KW, Shuster JJ, Murphy S, Pullen J, Camitta BA) Leukemia 2000 Dec;14(12):2276-85 PMID 11187919
  • Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma. (Pui CH, Mahmoud HH, Wiley JM, Woods GM, Leverger G, Camitta B, Hastings C, Blaney SM, Relling MV, Reaman GH) J Clin Oncol 2001 Feb 1;19(3):697-704 PMID 11157020
  • New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. (Schneider NR, Carroll AJ, Shuster JJ, Pullen DJ, Link MP, Borowitz MJ, Camitta BM, Katz JA, Amylon MD) Blood 2000 Oct 1;96(7):2543-9 PMID 11001909
  • Treatment of children with early pre-B and pre-B acute lymphocytic leukemia with antimetabolite-based intensification regimens: a Pediatric Oncology Group Study. (Harris MB, Shuster JJ, Pullen J, Borowitz MJ, Carroll AJ, Behm FG, Camitta B, Land VJ) Leukemia 2000 Sep;14(9):1570-6 PMID 10995002
  • Childhood Leukemias by C-H Pui, MD (ed); Cambridge University Press, 1999, 567 pages. (Camitta BM) Leukemia 2000 Jul;14(7):1332 PMID 10918555
  • Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821. (Chang M, Raimondi SC, Ravindranath Y, Carroll AJ, Camitta B, Gresik MV, Steuber CP, Weinstein H) Leukemia 2000 Jul;14(7):1201-7 PMID 10914543
  • Slow disappearance of peripheral blood blasts is an adverse prognostic factor in childhood T cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. (Griffin TC, Shuster JJ, Buchanan GR, Murphy SB, Camitta BM, Amylon MD) Leukemia 2000 May;14(5):792-5 PMID 10803508
  • Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. (Aricò M, Valsecchi MG, Camitta B, Schrappe M, Chessells J, Baruchel A, Gaynon P, Silverman L, Janka-Schaub G, Kamps W, Pui CH, Masera G) N Engl J Med 2000 Apr 6;342(14):998-1006 PMID 10749961
  • Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report. (Laver JH, Barredo JC, Amylon M, Schwenn M, Kurtzberg J, Camitta BM, Pullen J, Link MP, Borowitz M, Ravindranath Y, Murphy SB, Shuster J) Leukemia 2000 Mar;14(3):369-73 PMID 10720128
  • Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study. (Mahoney DH Jr, Shuster JJ, Nitschke R, Lauer S, Steuber CP, Camitta B) J Clin Oncol 2000 Mar;18(6):1285-94 PMID 10715299
  • What is the definition of cure for aplastic anemia? (Camitta BM) Acta Haematol 2000;103(1):16-8 PMID 10705154
  • Acute lymphoblastic leukemia with an unusual t(8;14)(q11.2;q32): a Pediatric Oncology Group Study. (Kaleem Z, Shuster JJ, Carroll AJ, Borowitz MJ, Pullen DJ, Camitta BM, Zutter MM, Watson MS) Leukemia 2000 Feb;14(2):238-40 PMID 10673739
  • Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid malignancies. (Woo MH, Shuster JJ, Chen C, Bash RO, Behm FG, Camitta B, Felix CA, Kamen BA, Pui CH, Raimondi SC, Winick NJ, Amylon MD, Relling MV) Leukemia 2000 Feb;14(2):232-7 PMID 10673738
  • Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. (Pollock BH, DeBaun MR, Camitta BM, Shuster JJ, Ravindranath Y, Pullen DJ, Land VJ, Mahoney DH Jr, Lauer SJ, Murphy SB) J Clin Oncol 2000 Feb;18(4):813-23 PMID 10673523
  • Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. (Davies SM, Ramsay NK, Klein JP, Weisdorf DJ, Bolwell B, Cahn JY, Camitta BM, Gale RP, Giralt S, Heilmann C, Henslee-Downey PJ, Herzig RH, Hutchinson R, Keating A, Lazarus HM, Milone GA, Neudorf S, Perez WS, Powles RL, Prentice HG, Schiller G, Socié G, Vowels M, Wiley J, Yeager A, Horowitz MM) J Clin Oncol 2000 Jan;18(2):340-7 PMID 10637248
  • Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study. (Pullen J, Shuster JJ, Link M, Borowitz M, Amylon M, Carroll AJ, Land V, Look AT, McIntyre B, Camitta B) Leukemia 1999 Nov;13(11):1696-707 PMID 10557041
  • Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation. (Rubnitz JE, Camitta BM, Mahmoud H, Raimondi SC, Carroll AJ, Borowitz MJ, Shuster JJ, Link MP, Pullen DJ, Downing JR, Behm FG, Pui CH) J Clin Oncol 1999 Jan;17(1):191-6 PMID 10458233
  • Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. (Amylon MD, Shuster J, Pullen J, Berard C, Link MP, Wharam M, Katz J, Yu A, Laver J, Ravindranath Y, Kurtzberg J, Desai S, Camitta B, Murphy SB) Leukemia 1999 Mar;13(3):335-42 PMID 10086723
  • Accumulation of methotrexate polyglutamates, ploidy and trisomies of both chromosomes 4 and 10 in lymphoblasts from children with B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group Study. (Whitehead VM, Vuchich MJ, Cooley LD, Lauer SJ, Mahoney DH, Shuster JJ, Payment C, Koch PA, Akabutu JJ, Bowen T, Kamen BA, Ravindranath Y, Emami A, Look AT, Beardsley GP, Pullen DJ, Camitta B) Leuk Lymphoma 1998 Nov;31(5-6):507-19 PMID 9922041
  • Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study. (Borowitz MJ, Rubnitz J, Nash M, Pullen DJ, Camitta B) Leukemia 1998 Nov;12(11):1764-70 PMID 9823952
  • Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. (Shuster JJ, Wacker P, Pullen J, Humbert J, Land VJ, Mahoney DH Jr, Lauer S, Look AT, Borowitz MJ, Carroll AJ, Camitta B) J Clin Oncol 1998 Aug;16(8):2854-63 PMID 9704739
  • Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: A Pediatric Oncology Group Pilot Study. (Lauer SJ, Camitta BM, Leventhal BG, Mahoney D Jr, Shuster JJ, Kiefer G, Pullen J, Steuber CP, Carroll AJ, Kamen B) J Pediatr Hematol Oncol 1998 May-Jun;20(3):229-33 PMID 9628434
  • T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up. (Juckett M, Rowlings P, Hessner M, Keever-Taylor C, Burns W, Camitta B, Casper J, Drobyski WR, Hanson G, Horowitz M, Lawton C, Margolis J, Peitryga D, Vesole D) Bone Marrow Transplant 1998 May;21(9):893-9 PMID 9613781
  • Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study. (Mahoney DH Jr, Shuster JJ, Nitschke R, Lauer SJ, Steuber CP, Winick N, Camitta B) J Clin Oncol 1998 May;16(5):1712-22 PMID 9586883
  • Translocations involving chromosome 12p11-13, methotrexate metabolism, and outcome in childhood B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. (Whitehead VM, Vuchich MJ, Cooley L, Lauer SJ, Mahoney DH, Shuster JJ, Payment C, Bernstein ML, Akabutu JJ, Bowen T, Kamen BA, Watson MS, Look AT, Pullen DJ, Camitta B) Clin Cancer Res 1998 Jan;4(1):183-8 PMID 9516969
  • Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia. (Passweg JR, Tiberghien P, Cahn JY, Vowels MR, Camitta BM, Gale RP, Herzig RH, Hoelzer D, Horowitz MM, Ifrah N, Klein JP, Marks DI, Ramsay NK, Rowlings PA, Weisdorf DJ, Zhang MJ, Barrett AJ) Bone Marrow Transplant 1998 Jan;21(2):153-8 PMID 9489632
  • Adoptive immunotherapy for leukemia: donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction. HGTRI 0103. (Link CJ Jr, Burt RK, Traynor AE, Drobyski WR, Seregina T, Levy JP, Gordon L, Rosen ST, Burns WH, Camitta B, Casper J, Horowitz M, Juckett M, Lawton C, Margolis D, Pietryga D, Rowlings P, Taylor C, Furtado M, Stefka J, Gupta-Burt S, Kaiser H, Vesole DH) Hum Gene Ther 1998 Jan 1;9(1):115-34 PMID 9458247
  • E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): a Pediatric Oncology Group study. (Hunger SP, Fall MZ, Camitta BM, Carroll AJ, Link MP, Lauer SJ, Mahoney DH, Pullen DJ, Shuster JJ, Steuber CP, Cleary ML) Blood 1998 Feb 1;91(3):1021-8 PMID 9446665
  • Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial. (Mahoney DH Jr, Shuster J, Nitschke R, Lauer SJ, Winick N, Steuber CP, Camitta B) J Clin Oncol 1998 Jan;16(1):246-54 PMID 9440749
  • Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B-precursor acute lymphoblastic leukemia in children. (Matherly LH, Taub JW, Wong SC, Simpson PM, Ekizian R, Buck S, Williamson M, Amylon M, Pullen J, Camitta B, Ravindranath Y) Blood 1997 Jul 15;90(2):578-89 PMID 9226157
  • Bone marrow transplantation for severe aplastic anemia: has outcome improved? (Passweg JR, Socié G, Hinterberger W, Bacigalupo A, Biggs JC, Camitta BM, Champlin RE, Gale RP, Gluckman E, Gordon-Smith EC, Hows JM, Klein JP, Nugent ML, Pasquini R, Rowlings PA, Speck B, Tichelli A, Zhang MJ, Horowitz MM, Bortin MM) Blood 1997 Jul 15;90(2):858-64 PMID 9226187
  • Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation. (Kawanishi Y, Passweg J, Drobyski WR, Rowlings P, Cook-Craig A, Casper J, Pietryga D, Garbrecht F, Camitta B, Horowitz M, Juckett M, Margolis D, Flomenberg N, Keever-Taylor CA) Bone Marrow Transplant 1997 Jun;19(11):1069-77 PMID 9193748
  • Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study. (Borowitz MJ, Shuster J, Carroll AJ, Nash M, Look AT, Camitta B, Mahoney D, Lauer SJ, Pullen DJ) Blood 1997 Jun 1;89(11):3960-6 PMID 9166833
  • Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group study. (Rubnitz JE, Shuster JJ, Land VJ, Link MP, Pullen DJ, Camitta BM, Pui CH, Downing JR, Behm FG) Blood 1997 Feb 15;89(4):1143-6 PMID 9028935
  • Biology and treatment of acute lymphocytic leukemia in children. (Camitta BM, Pullen J, Murphy S) Semin Oncol 1997 Feb;24(1):83-91 PMID 9045307
  • Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults. (Margolis D, Camitta B, Pietryga D, Keever-Taylor C, Baxter-Lowe LA, Pierce K, Kupst MJ, French J 3rd, Truitt R, Lawton C, Murray K, Garbrecht F, Flomenberg N, Casper J) Br J Haematol 1996 Jul;94(1):65-72 PMID 8757510
  • Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group. (Ravindranath Y, Yeager AM, Chang MN, Steuber CP, Krischer J, Graham-Pole J, Carroll A, Inoue S, Camitta B, Weinstein HJ) N Engl J Med 1996 May 30;334(22):1428-34 PMID 8618581
  • Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric Oncology Group randomized phase II study. (Steuber CP, Krischer J, Holbrook T, Camitta B, Land V, Sexauer C, Mahoney D, Weinstein H) J Clin Oncol 1996 May;14(5):1521-5 PMID 8622066
  • High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study. (Mahoney DH Jr, Strother D, Camitta B, Bowen T, Ghim T, Pick T, Wall D, Yu L, Shuster JJ, Friedman H) J Clin Oncol 1996 Feb;14(2):382-8 PMID 8636747
  • Changes in red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the treatment of acute lymphocytic leukemia in children: a pediatric oncology group study. (Graham ML, Shuster JJ, Kamen BA, Land VJ, Borowitz MJ, Camitta B, Cheo DL, Harrison MP, Leventhal BG, Pinkel DP, Pullen DJ, Steuber P, Whitehead VM) Clin Cancer Res 1996 Feb;2(2):331-7 PMID 9816176
  • Treatment of rhabdomyosarcoma. (Camitta BM) J Clin Oncol 1996 Jan;14(1):323 PMID 8558216
  • Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. (Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui CH, Pullen J, Reamon G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R) J Clin Oncol 1996 Jan;14(1):18-24 PMID 8558195
  • Bone marrow transplantation for Fanconi anemia. (Gluckman E, Auerbach AD, Horowitz MM, Sobocinski KA, Ash RC, Bortin MM, Butturini A, Camitta BM, Champlin RE, Friedrich W, Good RA, Gordon-Smith EC, Harris RE, Klein JP, Ortega JJ, Pasquini R, Ramsay NK, Speck B, Vowels MR, Zhang MJ, Gale RP) Blood 1995 Oct 1;86(7):2856-62 PMID 7670120
  • Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation. (Sarode R, McFarland JG, Flomenberg N, Casper JT, Cohen EP, Drobyski WR, Ash RC, Horowitz MM, Camitta B, Lawton C) Bone Marrow Transplant 1995 Aug;16(2):271-5 PMID 7581147
  • Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study. (Mahoney DH Jr, Camitta BM, Leventhal BG, Shuster JJ, Civin CJ, Ganick DJ, Lauer SJ, Steuber CP, Kamen BA) Cancer 1995 May 15;75(10):2623-31 PMID 7736409
  • Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. (Casper J, Camitta B, Truitt R, Baxter-Lowe LA, Bunin N, Lawton C, Murray K, Hunter J, Pietryga D, Garbrecht F) Blood 1995 May 1;85(9):2354-63 PMID 7727769
  • Crystallization and preliminary x-ray studies of NADPH-cytochrome P450 reductase. (Djordjevic S, Roberts DL, Wang M, Shea T, Camitta MG, Masters BS, Kim JJ) Proc Natl Acad Sci U S A 1995 Apr 11;92(8):3214-8 PMID 7724541
  • Use of solid phase automated sequencing to define HLA disparity between bone marrow donors and recipients. (Baxter-Lowe LA, Keever C, Dinauer D, Daniels T, Johnson K, Camitta B, Drobyski W, Garbrecht F, Horowitz M, Pietryga D) Transplant Proc 1995 Feb;27(1):1377-8 PMID 7878917
  • Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. (Barrett AJ, Horowitz MM, Pollock BH, Zhang MJ, Bortin MM, Buchanan GR, Camitta BM, Ochs J, Graham-Pole J, Rowlings PA) N Engl J Med 1994 Nov 10;331(19):1253-8 PMID 7935682
  • Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group study. (Camitta B, Mahoney D, Leventhal B, Lauer SJ, Shuster JJ, Adair S, Civin C, Munoz L, Steuber P, Strother D) J Clin Oncol 1994 Jul;12(7):1383-9 PMID 8021728
  • Increasing incidence of adenovirus disease in bone marrow transplant recipients. (Flomenberg P, Babbitt J, Drobyski WR, Ash RC, Carrigan DR, Sedmak GV, McAuliffe T, Camitta B, Horowitz MM, Bunin N) J Infect Dis 1994 Apr;169(4):775-81 PMID 8133091
  • Use of irradiated lymphocytes from immune donors for treatment of disseminated varicella. (Camitta B, Chusid MJ, Starshak RJ, Gottschall JL) J Pediatr 1994 Apr;124(4):593-6 PMID 8151475
  • Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. (Drobyski WR, Ash RC, Casper JT, McAuliffe T, Horowitz MM, Lawton C, Keever C, Baxter-Lowe LA, Camitta B, Garbrecht F) Blood 1994 Apr 1;83(7):1980-7 PMID 8142664
  • Effect of abrupt discontinuation of high glucose infusion rates during parenteral nutrition. (Werlin SL, Wyatt D, Camitta B) J Pediatr 1994 Mar;124(3):441-4 PMID 8120718
  • Acute lymphoidic leukemia in a patient with thrombocytopenia/absent radii (Tar) syndrome. (Camitta BM, Rock A) Am J Pediatr Hematol Oncol 1993 Aug;15(3):335-7 PMID 8328649
  • Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study. (Lauer SJ, Camitta BM, Leventhal BG, Mahoney DH Jr, Shuster JJ, Adair S, Casper JT, Civin CI, Graham M, Kiefer G) Cancer 1993 May 1;71(9):2854-61 PMID 8467463
  • Immunological evaluation of pediatric cancer patients receiving recombinant interleukin-2 in a phase I trial. (Truitt RL, Piaskowski V, Kirchner P, McOlash L, Camitta BM, Casper JT) J Immunother (1991) 1992 May;11(4):274-85 PMID 1599913
  • Allogeneic marrow transplantation using T cell depletion for patients with juvenile chronic myelogenous leukemia without HLA-identical siblings. (Bunin NJ, Casper JT, Lawton C, Murray K, Camitta BM, Greenwood M, Geil J, Ash RC) Bone Marrow Transplant 1992 Feb;9(2):119-22 PMID 1571710
  • Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. (Gluckman E, Horowitz MM, Champlin RE, Hows JM, Bacigalupo A, Biggs JC, Camitta BM, Gale RP, Gordon-Smith EC, Marmont AM) Blood 1992 Jan 1;79(1):269-75 PMID 1728315
  • Allogeneic bone marrow transplants for Fanconi anemia. A preliminary report from the International Bone Marrow Transplant Registry. (Gluckman E, Auerbach A, Ash RC, Biggs JC, Bortin MM, Camitta BM, Champlin RE, Friedrich W, Gale RP, Good RA) Bone Marrow Transplant 1992;10 Suppl 1:53-7 PMID 1521091
  • Intensive sequential chemotherapy for children with acute myelogenous leukemia: VAPA, 80-035, and HI-C-Daze. (Grier HE, Gelber RD, Link MP, Camitta BP, Clavell LA, Weistein HJ) Leukemia 1992;6 Suppl 2:48-51 PMID 1374493
  • Unrelated donor marrow transplants for severe acquired aplastic anemia. (Hows J, Szydlo R, Anasetti C, Camitta B, Gajewski J, Gluckman E) Bone Marrow Transplant 1992;10 Suppl 1:102-6 PMID 1521081
  • Optic chiasm glioma associated with inappropriate secretion of antidiuretic hormone, cerebral ischemia, nonobstructive hydrocephalus and chronic ascites following ventriculoperitoneal shunting. (Tang TT, Whelan HT, Meyer GA, Strother DR, Blank EL, Camitta BM, Franciosi RA) Childs Nerv Syst 1991 Dec;7(8):458-61 PMID 1790531
  • Osteoblastoma response to chemotherapy. (Camitta B, Wells R, Segura A, Unni KK, Murray K, Dunn D) Cancer 1991 Sep 1;68(5):999-1003 PMID 1913494
  • Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. A Pediatric Oncology Group study. (Krischer JP, Ragab AH, Kun L, Kim TH, Laurent JP, Boyett JM, Cornell CJ, Link M, Luthy AR, Camitta B) J Neurosurg 1991 Jun;74(6):905-9 PMID 2033450
  • Toxicity trials of amsacrine (AMSA) and etoposide +/- azacitidine (AZ) in childhood acute non-lymphocytic leukemia (ANLL): a pilot study. (Steuber CP, Holbrook T, Camitta B, Land VJ, Sexauer C, Krischer J) Invest New Drugs 1991 May;9(2):181-4 PMID 1714886
  • Toxicity of high-dose cytosine arabinoside in the treatment of advanced childhood tumors resistant to conventional therapy. A Pediatric Oncology Group study. (Tebbi CK, Krischer J, Fernbach DJ, Mahoney DH, Alvarado C, Camitta B) Cancer 1990 Nov 15;66(10):2064-7 PMID 2224760
  • Autoimmune thyroiditis after bone marrow transplantation. (Wyatt DT, Lum LG, Casper J, Hunter J, Camitta B) Bone Marrow Transplant 1990 May;5(5):357-61 PMID 2350629
  • Inflammatory myofibrohistiocytic proliferation simulating sarcoma in children. (Tang TT, Segura AD, Oechler HW, Harb JM, Adair SE, Gregg DC, Camitta BM, Franciosi RA) Cancer 1990 Apr 1;65(7):1626-34 PMID 2311072
  • Intensive sequential chemotherapy for children with acute myelogenous leukemia. (Grier HE, Gelber RD, Clavell LA, Camitta BM, Link MP, Garcea MJ, Weinstein HJ) Haematol Blood Transfus 1990;33:193-7 PMID 2182411
  • Immunosuppressive therapy for aplastic anemia: indications, agents, mechanisms, and results. (Camitta BM, Doney K) Am J Pediatr Hematol Oncol 1990;12(4):411-24 PMID 2285122
  • Treatment of meningeal relapse in childhood acute lymphoblastic leukemia: II. A prospective study of intellectual loss specific to CNS relapse and therapy. (Longeway K, Mulhern R, Crisco J, Kun L, Lauer S, Casper J, Camitta B, Hoffman RG) Am J Pediatr Hematol Oncol 1990;12(1):45-50 PMID 2309979
  • Bone marrow transplantation for children with severe aplastic anemia: use of donors other than HLA-identical siblings. (Camitta B, Ash R, Menitove J, Murray K, Lawton C, Hunter J, Casper J) Blood 1989 Oct;74(5):1852-7 PMID 2529004
  • Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study. (Camitta B, Leventhal B, Lauer S, Shuster JJ, Adair S, Casper J, Civin C, Graham M, Mahoney D, Munoz L) J Clin Oncol 1989 Oct;7(10):1539-44 PMID 2778483
  • Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. (Barrett AJ, Horowitz MM, Gale RP, Biggs JC, Camitta BM, Dicke KA, Gluckman E, Good RA, Herzig RH, Lee MB) Blood 1989 Aug 1;74(2):862-71 PMID 2665858
  • Long-term follow-up of parental adjustment following a child's death at home or hospital. (Lauer ME, Mulhern RK, Schell MJ, Camitta BM) Cancer 1989 Mar 1;63(5):988-94 PMID 2914304
  • Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. (Champlin RE, Horowitz MM, van Bekkum DW, Camitta BM, Elfenbein GE, Gale RP, Gluckman E, Good RA, Rimm AA, Rozman C) Blood 1989 Feb;73(2):606-13 PMID 2644980
  • Identification of leukemic cells in the cerebrospinal fluid from children with acute lymphoblastic leukemia: advances and dilemmas. (Lauer SJ, Kirchner PA, Camitta BM) Am J Pediatr Hematol Oncol 1989;11(1):64-73 PMID 2653078
  • Oral fluconazole for treatment of disseminated fungal infection. (Bunin N, Camitta B) Pediatr Infect Dis J 1989 Jan;8(1):62 PMID 2537947
  • Partially matched bone marrow transplantation in patients with myelodysplastic syndromes. (Bunin NJ, Casper JT, Chitambar C, Hunter J, Truitt R, Menitove J, Camitta BM, Ash R) J Clin Oncol 1988 Dec;6(12):1851-5 PMID 3058877
  • Intravenous immunoglobulin may lessen all forms of infection in patients receiving allogeneic bone marrow transplantation for acute lymphoblastic leukemia: a pediatric oncology group study. (Graham-Pole J, Camitta B, Casper J, Elfenbein G, Gross S, Herzig R, Koch P, Mahoney D, Marcus R, Munoz L) Bone Marrow Transplant 1988 Nov;3(6):559-66 PMID 3063324
  • Criteria for severe aplastic anaemia. (Camitta BM) Lancet 1988 Feb 6;1(8580):303-4 PMID 2893118
  • Management of children with cancer. (Lauer SJ, Camitta BM) Wis Med J 1987 Sep;86(9):31-2 PMID 3687049
  • Prognostic factors in childhood acute myelogenous leukemia. (Grier HE, Gelber RD, Camitta BM, Delorey MJ, Link MP, Price KN, Leavitt PR, Weinstein HJ) J Clin Oncol 1987 Jul;5(7):1026-32 PMID 3474356
  • Close association of accelerated rates of whole body protein turnover (synthesis and breakdown) and energy expenditure in children with newly diagnosed acute lymphocytic leukemia. (Kien CL, Camitta BM) JPEN J Parenter Enteral Nutr 1987 Mar-Apr;11(2):129-34 PMID 3473242
  • Postremission induction intensive sequential chemotherapy for children with AML--treatment results and prognostic factors. (Weinstein H, Grier H, Gelber R, Camitta B, Link M, Delorey M, Price K) Haematol Blood Transfus 1987;30:88-92 PMID 3476388
  • Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group Study. (Rivera GK, Buchanan G, Boyett JM, Camitta B, Ochs J, Kalwinsky D, Amylon M, Vietti TJ, Crist WM) N Engl J Med 1986 Jul 31;315(5):273-8 PMID 3523250
  • Treatment of refractory acute lymphoblastic leukemia with teniposide and cytarabine. (Kamen BA, Casper J, Lauer S, Camitta BM, Holcenberg JS) Cancer Treat Rep 1986 Jul;70(7):935-6 PMID 3459577
  • Childhood primary cutaneous non-T/non-B lymphoma followed by acute T-cell leukemia. (Tang TT, Lauer SJ, Harb JM, Kirchner PA, Adair SE, Camitta BM) Cancer 1986 Jun 15;57(12):2368-74 PMID 3486034
  • Utilization of hospice/home care in pediatric oncology. A national survey. (Lauer ME, Mulhern RK, Hoffmann RG, Camitta BM) Cancer Nurs 1986 Jun;9(3):102-7 PMID 3636172
  • Cyclic neutropenia in identical twins. (Chusid MJ, Casper JT, Camitta BM, McCreadie SR) Am J Med 1986 May;80(5):994-6 PMID 3706384
  • Cerebral toxoplasmosis in an immunocompromised host. A precise and rapid diagnosis by electron microscopy. (Tang TT, Harb JM, Dunne WM Jr, Wells RG, Meyer GA, Chusid MJ, Casper JT, Camitta BM) Am J Clin Pathol 1986 Jan;85(1):104-10 PMID 3940413
  • Isolated bilateral T-cell renal lymphoblastic lymphoma. (Camitta BM, Casper JT, Kun LE, Lauer SJ, Starshak RJ, Oechler HW) Am J Pediatr Hematol Oncol 1986;8(1):8-12 PMID 3487255
  • Effectiveness of a six-drug regimen (APO) without local irradiation for treatment of mediastinal lymphoblastic lymphoma in children. (Camitta BM, Lauer SJ, Casper JT, Kirchner PA, Kun LE, Oechler HW, Adair SE) Cancer 1985 Aug 15;56(4):738-41 PMID 3839432
  • Children's perceptions of their sibling's death at home or hospital: the precursors of differential adjustment. (Lauer ME, Mulhern RK, Bohne JB, Camitta BM) Cancer Nurs 1985 Feb;8(1):21-7 PMID 3844963
  • Terminal transferase surveillance of remission bone marrows in childhood acute lymphoblastic leukemia: improved sensitivity with countercurrent centrifugal elutriation. (Lauer SJ, Lyman S, Kirchner PA, Gottschall JL, Camitta BM, Casper JT) J Clin Lab Immunol 1985 Jan;16(1):17-22 PMID 3856682
  • Editors have ethical responsibilities, too. (Chusid MJ, Casper JT, Camitta BM) N Engl J Med 1984 Oct 11;311(15):990-1 PMID 6472434
  • Treatment of meningeal relapse in childhood acute lymphoblastic leukemia. I. Results of craniospinal irradiation. (Kun LE, Camitta BM, Mulhern RK, Lauer SJ, Kline RW, Casper JT, Kamen BA, Kaplan BM, Barber SW) J Clin Oncol 1984 May;2(5):359-64 PMID 6587015
  • Methemoglobinemia in an infant treated with the folk remedy glycerited asafoetida. (Kelly KJ, Neu J, Camitta BM, Honig GR) Pediatrics 1984 May;73(5):717-9 PMID 6609339
  • Pathogenesis and treatment of aplastic anemia. (Camitta BM) Rinsho Ketsueki 1984 Apr;25(4):459-69 PMID 6381789
  • A controlled prospective trial of antithoracic duct lymphocyte globulin (ATDLG) for treatment of severe aplastic anemia. (Camitta BM) Prog Clin Biol Res 1984;148:239-47 PMID 6379662
  • Multilocular renal cyst: electron microscopic evidence of pathogenesis. (Tang TT, Harb JM, Oechler HW, Camitta BM) Am J Pediatr Hematol Oncol 1984;6(1):27-32 PMID 6324606
  • Antithoracic duct lymphocyte globulin. (O'Reilly RJ, Camitta B, Nathan DG) Blood 1983 Dec;62(6):1304 PMID 6640112
  • Evaluation of cerebrospinal fluid mononuclear cells obtained from children with acute lymphocytic leukemia: advantages of combining cytomorphology and terminal deoxynucleotidyl transferase. (Casper JT, Lauer SJ, Kirchner PA, Gottschall JL, Camitta BM) Am J Clin Pathol 1983 Nov;80(5):666-70 PMID 6579834
  • Increased whole-body protein turnover in sick children with newly diagnosed leukemia or lymphoma. (Kien CL, Camitta BM) Cancer Res 1983 Nov;43(11):5586-92 PMID 6577952
  • Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia. (Camitta B, O'Reilly RJ, Sensenbrenner L, Rappeport J, Champlin R, Doney K, August C, Hoffmann RG, Kirkpatrick D, Stuart R, Santos G, Parkman R, Gale RP, Storb R, Nathan D) Blood 1983 Oct;62(4):883-8 PMID 6349719
  • Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update. (Weinstein HJ, Mayer RJ, Rosenthal DS, Coral FS, Camitta BM, Gelber RD) Blood 1983 Aug;62(2):315-9 PMID 6575837
  • Bone marrow transplantation for severe aplastic anemia using a phenotypically HLA-identical, SB-compatible unrelated donor. (Duquesnoy RJ, Zeevi A, Marrari M, Hackbarth S, Camitta B) Transplantation 1983 Jun;35(6):566-71 PMID 6223416
  • Hepatic ultrastructure in leukemic children treated with methotrexate and 6-mercaptopurine. (Harb JM, Werlin SL, Camitta BM, Oechler H, Kamin BA, Blank EL) Am J Pediatr Hematol Oncol 1983;5(4):323-31 PMID 6686921
  • The treatment of acute myelogenous leukemia in children and adults: VAPA update. (Weinstein HJ, Mayer RJ, Rosenthal DS, Coral FS, Camitta BM, Gelber RD, Nathan DG, Frei E 3rd) Haematol Blood Transfus 1983;28:41-5 PMID 6345291
  • A comparison study of parental adaptation following a child's death at home or in the hospital. (Lauer ME, Mulhern RK, Wallskog JM, Camitta BM) Pediatrics 1983 Jan;71(1):107-12 PMID 6848957
  • Doxorubicin-vincristine therapy for Wilms' tumor: a pilot study. (Camitta B, Kun L, Glicklich M, Oechler H, Adair S, Pinkel D) Cancer Treat Rep 1982 Oct;66(10):1791-4 PMID 6290049
  • Splenic torsion in an infant associated with secondary disseminated Hemophilus influenzae infection. (Kelly KJ, Chusid MJ, Camitta BM) Clin Pediatr (Phila) 1982 Jun;21(6):365-6 PMID 7075098
  • Aplastic anemia (second of two parts): pathogenesis, diagnosis, treatment, and prognosis. (Camitta BM, Storb R, Thomas ED) N Engl J Med 1982 Mar 25;306(12):712-8 PMID 7038485
  • Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis. (Camitta BM, Storb R, Thomas ED) N Engl J Med 1982 Mar 18;306(11):645-52 PMID 7035946
  • Doxorubicin cardiomyopathy in children with left-sided Wilms tumor. (Pinkel D, Camitta B, Kun L, Howarth C, Tang T) Med Pediatr Oncol 1982;10(5):483-8 PMID 6292680
  • Bone marrow and extramedullary variations of cell membrane antigen expression in childhood lymphoid neoplasias at relapse. (Lauer S, Piaskowski V, Camitta B, Casper J) Leuk Res 1982;6(6):769-74 PMID 6961270
  • Methotrexate accumulation and folate depletion in cells as a possible mechanism of chronic toxicity to the drug. (Kamen BA, Nylen PA, Camitta BM, Bertino JR) Br J Haematol 1981 Nov;49(3):355-60 PMID 6170307
  • Protein-energy nutritional status of pediatric cancer patients. (Kien CL, Camitta BM) Am J Clin Nutr 1981 Nov;34(11):2486-92 PMID 6795917
  • Patterns of communication among pediatric patients with leukemia, parents, and physicians: prognostic disagreements and misunderstandings. (Mulhern RK, Crisco JJ, Camitta BM) J Pediatr 1981 Sep;99(3):480-3 PMID 7264814
  • Primary cerebral germinoma and ventriculoperitoneal shunt metastasis. (Kun LE, Tang TT, Sty JR, Camitta BM) Cancer 1981 Jul 1;48(1):213-6 PMID 7237388
  • Neutropenia in dysgammaglobulinemia I: remission with immunoglobulin therapy. (Chusid MJ, Casper JT, Adair SE, Camitta BM) Wis Med J 1981 Mar;80(3):32-3 PMID 7281709
  • Recent approaches to the treatment of acute lymphocytic leukemia in childhood. (Holcenberg JS, Camitta BM) Annu Rev Pharmacol Toxicol 1981;21:231-49 PMID 7016005
  • Home care for dying children: a nursing model. (Lauer ME, Camitta BM) J Pediatr 1980 Dec;97(6):1032-5 PMID 7441412
  • Thyroid carcinoma following treatment for acute lymphoblastic leukemia. (Tang TT, Holcenberg JS, Duck SC, Hodach AE, Oechler HW, Camitta BM) Cancer 1980 Oct 1;46(7):1572-6 PMID 6932254
  • Treatment of acute myelogenous leukemia in children and adults. (Weinstein HJ, Mayer RJ, Rosenthal DS, Camitta BM, Coral FS, Nathan DG, Frei E 3rd) N Engl J Med 1980 Aug 28;303(9):473-8 PMID 6930539
  • Current therapy of childhood osteosarcoma and Ewing's sarcoma. (Jacobs PA, Camitta BM, Sullivan DM) Wis Med J 1980 Apr;79(4):22-4 PMID 6930133
  • Correction of infantile agranulocytosis (Kostmann's syndrome) by allogeneic bone marrow transplantation. (Rappeport JM, Parkman R, Newburger P, Camitta BM, Chusid MJ) Am J Med 1980 Apr;68(4):605-9 PMID 6989239
  • Congenital neutropenia: studies of pathogenesis. (Chusid MJ, Pisciotta AV, Duquesnoy RJ, Camitta BM, Tomasulo PA) Am J Hematol 1980;8(3):315-24 PMID 7416162
  • Failure of early intensive chemotherapy to improve prognosis in childhood acute lymphocytic leukemia. (Camitta BM, Pinkel D, Thatcher LG, Casper J, Kun LE, Lauer S) Med Pediatr Oncol 1980;8(4):383-9 PMID 7005645
  • Human pharmacology and toxicology of succinylated Acinetobacter glutaminase-asparaginase. (Holcenberg JS, Borella LD, Camitta BM, Ring BJ) Cancer Res 1979 Aug;39(8):3145-51 PMID 455299
  • Desacetyl vinblastine amide sulfate induced ineffective erythropoiesis. (Jumean HG, Camitta B, Holcenberg J, Hodach A) Cancer 1979 Jul;44(1):64-8 PMID 455265
  • Phase I study of succinylated acinetobacter L-glutaminase-L-asparaginase. (Holcenberg JS, Camitta BM, Borella LD, Ring BJ) Cancer Treat Rep 1979 Jun;63(6):1025-30 PMID 380800
  • Effect of androgen on growth hormone secretion and growth in boys with short stature. (Martin LG, Grossman MS, Connor TB, Levitsky LL, Clark JW, Camitta FD) Acta Endocrinol (Copenh) 1979 Jun;91(2):201-12 PMID 463446
  • A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. (Camitta BM, Thomas ED, Nathan DG, Gale RP, Kopecky KJ, Rappeport JM, Santos G, Gordon-Smith EC, Storb R) Blood 1979 Mar;53(3):504-14 PMID 32941
  • Pathogenesis of severe aplastic anemia: inferences from therapeutic trials. (Camitta BM) Haematol Blood Transfus 1979;24:161-5 PMID 396171
  • The role of viral infections in aplastic anemia. (Camitta BM) Haematol Blood Transfus 1979;24:39-46 PMID 540798
  • Successful use of multiagent immunosuppression in the bone marrow transplantation of sensitized patients. (Parkman R, Rappeport J, Camitta B, Levey RH, Nathan DG) Blood 1978 Dec;52(6):1163-9 PMID 363204
  • Severe aplastic anaemia: a prospective study of the effect of androgens or transplantation on haematological recovery and survival. (Camitta BM, Thomas ED) Clin Haematol 1978 Oct;7(3):587-95 PMID 363330
  • Hepatopathy following irradiation and adriamycin. (Kun LE, Camitta BM) Cancer 1978 Jul;42(1):81-4 PMID 667811
  • A.L.G. in aplastic anaemia. (Camitta BM) Lancet 1978 Mar 4;1(8062):504 PMID 76049
  • Prognostic value of antibody-dependent assays for presensitization in bone marrow transplant recipients. (Parkman R, Rappeport J, Camitta B, Levey R, Rosen FS) Transplant Proc 1978 Mar;10(1):71-3 PMID 345568
  • Safety of delayed leucovorin "rescue" following high-dose methotrexate in children. (Camitta BM, Holcenberg JS) Med Pediatr Oncol 1978;5(1):55-9 PMID 370536
  • Nephroblastoma (Wilms tumor): tubule density and prognosis. (Chambers CH, Camitta BM, Garg U, Tang TT, McCreadie SR) Med Pediatr Oncol 1978;5(1):127-35 PMID 218087
  • Acute erythroid hypoplasia in malnourished infant squirrel monkeys fed isolated soy protein. (Ausman LM, Gallina DL, Camitta BM, Flath LC, Hegsted DM) Am J Clin Nutr 1977 Oct;30(10):1713-20 PMID 410292
  • Bone marrow transplantation for an infant with neutrophil dysfunction. (Camitta BM, Quesenberry PJ, Parkman R, Boxer LA, Stossel TP, Cassady JR, Rappeport JM, Nathan DG) Exp Hematol 1977 Mar;5(2):109-16 PMID 321233
  • Dental management of patients undergoing bone marrow transplantation for aplastic anemia. (Lasser SD, Camitta BM, Needleman HL) Oral Surg Oral Med Oral Pathol 1977 Feb;43(2):181-9 PMID 13336
  • Clinical and cytokinetic aspects of remission induction of childhood acute lymphoblastic leukemia (ALL): addition of an anthracycline to vincristine and prednisone. (Sallan SE, Camitta BM, Frei E 3rd, Furman L, Leavitt P, Bishop Y, Jaffe N) Med Pediatr Oncol 1977;3(3):281-7 PMID 284168
  • Chemotherapy with cyclophosphamide, vincristine, cytosine arabinoside, and prednisone (COAP) in childhood acute lymphoblastic leukemia (ALL). (Sallan SE, Camitta BM, Chan DM, Traggis D, Jaffe N) Med Pediatr Oncol 1977;3(4):359-64 PMID 270608
  • Hla antigens and haplotypes in 200 patients with aplastic anemia. (Albert E, Thomas ED, Nisperos B, Storb R, Camitta BM, Parkman R) Transplantation 1976 Nov;22(5):528-31 PMID 996929
  • Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. (Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC, Gale RP, Rappeport JM, Storb R) Blood 1976 Jul;48(1):63-70 PMID 779871
  • The role of irradiation in central nervous system treatment and prophylaxis for acute lymphoblastic leukemia. (Dritschilo A, Cassady JR, Camitta B, Jaffe N, Furman L, Traggis D) Cancer 1976 Jun;37(6):2729-35 PMID 1065467
  • Detection of genetically determined histocompatibility antigen differences between HL-A identical and MLC nonreactive siblings. (Parkman R, Rosen FS, Rappeport J, Camitta B, Levey RL, Nathan DG) Transplantation 1976 Feb;21(2):110-6 PMID 129895
  • Development of an effective treatment program for childhood acute lymphocytic leukemia: a preliminary report. (Furman L, Camitta BM, Jaffe N, Sallan SE, Cassady JR, Traggis D, Leavitt P, Nathan DG, Frei E 3rd) Med Pediatr Oncol 1976;2(2):157-66 PMID 822270
  • Modification of gastrointestinal symptoms following irradiation by low dose rate technique. (Cassady JR, Order S, Camitta B, Marck A) Int J Radiat Oncol Biol Phys 1975 Oct-Nov;1(1-2):15-20 PMID 786963
  • Myelofibrosis-myeloid metaplasia in childhood. (Boxer LA, Camitta BM, Berenberg W, Fanning JP) Pediatrics 1975 Jun;55(6):861-5 PMID 1094402
  • Selection of patients for bone marrow transplantation in severe aplastic anemia. (Camitta BM, Rappeport JM, Parkman R, Nathan DG) Blood 1975 Mar;45(3):355-63 PMID 1090310
  • Anemia in adolescence. 2. Hemoglobinopathies and other causes. (Camitta BM, Nathan DG) Postgrad Med 1975 Feb;57(2):151-5 PMID 1109736
  • Anemia in adolescence. 1. Disturbances of iron balance. (Camitta BM, Nathan DG) Postgrad Med 1975 Feb;57(2):143-6 PMID 1109735
  • The medical ethics of bone marrow transplantation in childhood. (Levine MD, Camitta BM, Nathan D, Curran WJ) J Pediatr 1975 Jan;86(1):145-50 PMID 1089140
  • Posthepatitic severe aplastic anemia--an indication for early bone marrow transplantation. (Camitta BM, Nathan DG, Forman EN, Parkman R, Rappeport JM, Orellana TD) Blood 1974 Apr;43(4):473-83 PMID 4150267
  • Primary hyperparathyroidism with giant cell tumors of the maxilla: report of case. (Carlotti AE, Camitta FD, Connor TB) J Oral Surg 1969 Sep;27(9):722-7 PMID 5257229
  • A study in the pathogenesis of hyperlipemia in a patient with acromegaly and diabetes mellitus. (Camitta FD, Gray TK) Diabetes 1969 Jan;18(1):44-50 PMID 5761868
  • Cell wall composition and virulence in Escherichia coli. (Medearis DN Jr, Camitta BM, Heath EC) J Exp Med 1968 Sep 1;128(3):399-414 PMID 4875325
  • Grants and Awards

  • Pediatric Oncology Group-Midwest Children's Cancer Center (#9203277 03/01/2004 - 02/28/2005) Sponsor: National Childhood Cancer Foundation
  • Children's Oncology Group - Patient Reimbursement (#9204485 03/01/2007 - 02/29/2008) Sponsor: National Childhood Cancer Foundation
  • Children's Oncology Group (#9301162 11/14/1997 - 06/30/2017) Sponsor: Various